Emisphere Technologies Inc (OTCBB - OTCQB:EMIS)

Data as of 2:56pm ET
 -0.01 / -2.63%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Emisphere Technologies, Inc,. is a commercial stage specialty pharmaceutical company. It prepares to launch its first prescription product, oral Eligen B12 Rx, which provides a therapeutic equivalent to vitamin B12 injections. It also utilizes its broad-based proprietary oral drug delivery platform, Eligen Technology, to create new oral formulations of therapeutic agents. The company was founded in 1986 and is headquartered in Roseland, NJ.

Contact Information

Emisphere Technologies, Inc.
4 Becker Farm Road
Roseland New Jersey 07068
P:(973) 532-8000
Investor Relations:
(973) 532-8005



Individual stakeholders31.45%
Mutual fund holders--
Other institutional--

Top Executives

Alan L. RubinoPresident, CEO & Class II Director
Michael R. GaroneCFO, Secretary, Principal Accounting Officer & VP
M. Gary I. RileyChief Scientific Officer
Michael PerelmanChief Medical Officer
Carlos DeLeceaHead-Global Business Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.